|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
1,250,000,000 |
Market
Cap: |
147.33(B) |
Last
Volume: |
5,456,529 |
Avg
Vol: |
8,420,574 |
52
Week Range: |
$82.21 - $120.47 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ-100 |
|
S&P 500 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 425 |
Guru Rank Value : 4.8 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
76,500 |
122,000 |
885,519 |
983,597 |
Total Sell Value |
$8,760,706 |
$13,667,338 |
$86,697,460 |
$94,660,320 |
Total People Sold |
4 |
4 |
5 |
5 |
Total Sell Transactions |
10 |
15 |
27 |
38 |
End Date |
2025-06-15 |
2025-03-14 |
2024-09-13 |
2023-09-14 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wilfong Diane E |
Interim Corp Controller & CAO |
|
2025-09-10 |
4 |
D |
$115.25 |
$38,955 |
D/D |
(338) |
46,259 |
|
- |
|
Wilfong Diane E |
Interim Corp Controller & CAO |
|
2025-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
921 |
46,597 |
|
- |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-09-10 |
4 |
D |
$115.25 |
$570,372 |
D/D |
(4,949) |
601,203 |
|
- |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,427 |
606,152 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-09-10 |
4 |
D |
$115.25 |
$201,803 |
D/D |
(1,751) |
162,055 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,696 |
163,806 |
|
- |
|
Telman Deborah H |
EVP, Corporate Affairs & GC |
|
2025-09-10 |
4 |
D |
$115.25 |
$73,069 |
D/D |
(634) |
43,402 |
|
- |
|
Telman Deborah H |
EVP, Corporate Affairs & GC |
|
2025-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,315 |
44,036 |
|
- |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-09-10 |
4 |
D |
$115.25 |
$209,640 |
D/D |
(1,819) |
116,193 |
|
- |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,844 |
118,012 |
|
- |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-08-28 |
4 |
AS |
$113.63 |
$1,136,300 |
D/D |
(10,000) |
595,725 |
|
2% |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-08-15 |
4 |
AS |
$118.53 |
$296,325 |
D/D |
(2,500) |
160,110 |
|
-3% |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-08-15 |
4 |
AS |
$118.50 |
$3,318,927 |
D/D |
(28,000) |
114,168 |
|
-3% |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-08-15 |
4 |
OE |
$66.64 |
$1,666,000 |
D/D |
25,000 |
117,868 |
|
- |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-07-28 |
4 |
AS |
$113.17 |
$1,139,370 |
D/D |
(10,000) |
605,725 |
|
2% |
|
Telman Deborah H |
EVP, Corporate Affairs & GC |
|
2025-07-25 |
4 |
D |
$116.20 |
$444,233 |
D/D |
(3,823) |
42,721 |
|
- |
|
Telman Deborah H |
EVP, Corporate Affairs & GC |
|
2025-07-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,743 |
46,544 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-07-15 |
4 |
AS |
$111.03 |
$277,575 |
D/D |
(2,500) |
162,610 |
|
5% |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-07-15 |
4 |
AS |
$111.03 |
$333,090 |
D/D |
(3,000) |
117,168 |
|
5% |
|
Bluestone Jeffrey |
Director |
|
2025-07-14 |
4 |
AS |
$109.74 |
$548,700 |
D/D |
(5,000) |
8,920 |
|
3% |
|
Bluestone Jeffrey |
Director |
|
2025-07-14 |
4 |
OE |
$67.45 |
$337,250 |
D/D |
5,000 |
13,920 |
|
- |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-06-30 |
4 |
AS |
$110.40 |
$1,104,484 |
D/D |
(10,000) |
615,725 |
|
4% |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-06-16 |
4 |
AS |
$110.17 |
$275,425 |
D/D |
(2,500) |
165,110 |
|
4% |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-06-16 |
4 |
AS |
$110.17 |
$330,510 |
D/D |
(3,000) |
120,168 |
|
4% |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-06-10 |
4 |
D |
$110.09 |
$193,538 |
D/D |
(1,758) |
167,610 |
|
- |
|
959 Records found
|
|
Page 1 of 39 |
|
|